Zeting Yuan

Shanghai University of Traditional Chinese Medicine — China

Engineering · Physical Sciences

19h-index1.3kcitations34works14.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nanoplatforms for cancer theranostics(10), Nanoparticle-Based Drug Delivery(5), Cancer, Hypoxia, and Metabolism(5), MicroRNA in disease regulation(3), Cancer Cells and Metastasis(3)

Publications34 total

Association between weight fluctuation and the risk of metabolic dysfunction-associated steatotic liver disease
World Journal of Hepatology·2025Open Access
Injectable sodium alginate/4-arm polyethylene glycol-lipoic acid double-network hydrogel loading Ca2+-tannic acid nanocomposite treats periodontitis via anti-bacteria, ROS scavenging and osteogenesis
International Journal of Biological Macromolecules·2025· 2 cited
Chang-Wei-Qing Combined with PD-1 Inhibitor Alleviates Colitis-Associated Colorectal Tumorigenesis by Modulating the Gut Microbiota and Restoring Intestinal Barrier
Biological Procedures Online·2024· 7 citedOpen Access
Photothermal Fe3O4 nanoparticles induced immunogenic ferroptosis for synergistic colorectal cancer therapy
Journal of Nanobiotechnology·2024· 57 citedOpen Access
Bufalin-Loaded Multifunctional Photothermal Nanoparticles Inhibit the Anaerobic Glycolysis by Targeting SRC-3/HIF-1α Pathway for Improved Mild Photothermal Therapy in CRC
International Journal of Nanomedicine·2024· 6 citedOpen Access
New horizons in the mechanisms and therapeutic strategies for PD-L1 protein degradation in cancer
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer·2024· 10 cited
Spatiotemporally controlled Pseudomonas exotoxin transgene system combined with multifunctional nanoparticles for breast cancer antimetastatic therapy
Journal of Controlled Release·2024· 16 cited
Sequential Rocket-Mode Bioactivating Ticagrelor Prodrug Nanoplatform Combining Light-Switchable Diphtherin Transgene System for Breast Cancer Metastasis Inhibition
ACS Applied Materials & Interfaces·2023· 6 cited
Hydrogen sulfide responsive nanoplatforms: Novel gas responsive drug delivery carriers for biomedical applications
Asian Journal of Pharmaceutical Sciences·2023· 19 citedOpen Access
Polydopamine-coated ferric oxide nanoparticles for R848 delivery for photothermal immunotherapy in breast cancer
International Journal of Pharmaceutics·2023· 11 cited
Bufalin-loaded vitamin E succinate-grafted chitosan oligosaccharide/RGD-conjugated TPGS mixed micelles inhibit intraperitoneal metastasis of ovarian cancer
Cancer Nanotechnology·2023· 4 citedOpen Access
Spatiotemporally controllable diphtherin transgene system and neoantigen immunotherapy
Journal of Controlled Release·2023· 7 cited
Bufalin exacerbates Photodynamic therapy of colorectal cancer by targeting SRC-3/HIF-1α pathway
International Journal of Pharmaceutics·2022· 28 cited
Chemotherapy may facilitate colorectal cancer metastasis through vessel formation by upregulating G-CSF
Research Square (Research Square)·2022Open Access
Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signalling pathway
Journal of Translational Medicine·2021· 46 citedOpen Access
Photodynamic therapy synergizes with PD-L1 checkpoint blockade for immunotherapy of CRC by multifunctional nanoparticles
Molecular Therapy·2021· 125 citedOpen Access
Bufalin targets the SRC-3/MIF pathway in chemoresistant cells to regulate M2 macrophage polarization in colorectal cancer
Cancer Letters·2021· 57 cited
Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signaling pathway
Research Square (Research Square)·2021· 1 citedOpen Access
A combination of LightOn gene expression system and tumor microenvironment-responsive nanoparticle delivery system for targeted breast cancer therapy
Acta Pharmaceutica Sinica B·2020· 22 citedOpen Access
Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer
British Journal of Cancer·2020· 58 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Peihao Yin(23), Feng Gao(14), Ke Xu(13), Yanyan Qiu(12), Yueping Zhan(9), Minbo Lan(7), Guohua Fan(5), Yijun Cao(5), Muye He(5), Yuzheng Zhao(5), Xianjun Chen(5), Xin Liang(4), Chenting Shou(4), Xinyu Hou(4), Jiajun Xu(4), Yi Yang(4), Jiafeng Zou(4), Jun Zhang(3), Wen Peng(3), Xia Yuan(3)